‘Bar Rescue’ Star Jon Taffer Reveals ‘Common Denominator For Failure’ At VeeCon 2023
Jon Taffer, entrepreneur and star of Paramount Global's (NASDAQ: PARA) "Bar Rescue," has helped save hundreds of failing businesses.
Busta Rhymes Felt Like He Knew Gary Vee Before They Met: ‘His Level Of Captivating Energy Is Profound’
Ever feel like you know someone even though you've never met them? That's how one famous rapper felt about a famous entrepreneur he had only seen in social media videos ahead of VeeCon 2023.
Phase 1/2 Interim Data On Moderna’s mRNA-3927, An Investigational mRNA Therapy For Propionic Acidemia, Presented At The 2023 ASGCT Annual Meeting
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
To date, mRNA-3927 has been generally well-tolerated at the doses administered, with encouraging early signs of
Aziyo Biologics Presents Clinical Data On CanGaroo Biologic Envelope
Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices
SILVER SPRING, Md., May 19, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc.
The Flaming Lips, Eric Andre & Reggie Watts And Many More At MAPS 2023 Psychedelic Event
MAPS’ Psychedelic Science 2023 is taking place this June in Denver.
Biden, G7 Leaders To Discuss Ukraine War, Taiwan, North Korea Nuclear Threat, AI And More At Meeting In Hiroshima
The G7 summit, held this year in the city of Hiroshima in Japan, will focus on strengthening Western nations' unity and cooperation against global geopolitical challenges.
Setting The Stage For VeeCon 2023: Gary Vee’s Super Conference Arrives In The ‘Practical And Emotional’ Indianapolis
Multi-day super conference VeeCon launched as the first NFT-ticketed conference last year in Minneapolis. The conference has returned to the Midwest in its second year — this time in Indianapolis.
Adverum Biotechnologies Presents Nonclinical Data In Support Of Ixo-vec’s Phase 2 Clinical Development At ASGCT 2023 Annual Meeting
Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced new nonclinical data
Cellectis Presents Clinical Data On AMELI-01 and Preclinical Data On Multiplex Engineering For Superior Generation Of CAR T-cells At ASGCT 2023
Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today presents clinical data on its
One Tesla Analyst Expects Shares To Accelerate, Another Sees The Stock Reversing Following EV Company’s Shareholder Meeting
Tesla Inc (NASDAQ: TSLA) held its annual shareholder meeting at its Texas gigafactory on Tuesday.